<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800016769</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-06-22</date_registration>
      <primary_sponsor>Xiangtan Central Hospital </primary_sponsor>
      <public_title>A prospective study on the treatment with autologus endometrial stem cells transplantation.</public_title>
      <acronym />
      <scientific_title>A prospective study on the treatment with autologus endometrial stem cells transplantation.</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2018-07-01</date_enrolment>
      <type_enrolment />
      <target_size>Group1:40;Group2:40;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=27042</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Thin endometrium</hc_freetext>
      <i_freetext>Group1:Hormonal manipulation;Group2:autologus endometrial stem cells transplantation and Hormonal manipulation;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Peng E'na</firstname>
        <middlename />
        <lastname />
        <address>120 Heping Road, Yuhu District, Xiangtan, Hu'nan, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15173290738</telephone>
        <email>653541801@qq.com</email>
        <affiliation>Xiangtan Central Hospital</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Tan Xiaojun</firstname>
        <middlename />
        <lastname />
        <address>120 Heping Road, Yuhu District, Xiangtan, Hu'nan, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13087329800</telephone>
        <email>Changdaot@163.com</email>
        <affiliation>Xiangtan Central Hospital</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged between 20 and 40 years;
2. Endometrial thickness &lt; 6 mm;
3. Presence of menstrual bleeding with Natural Cycle;
4. Normal liver, heart, and kidney function;
5. Absence of HIV, Hepatitis B or C, syphilis and psychiatric pathology;
6. Serum Î²-hCG is negative.</inclusion_criteria>
      <agemin>20</agemin>
      <agemax>40</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having a history of malignant tumor</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Endometrial thickness;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Endometrial blood flow;Endometrial volume;Ongoing pregnancy rate;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>self-financing</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-03-22</approval_date>
        <contact_name>Zeng jianping</contact_name>
        <contact_address>120 Heping Road, Yuhu District, Xiangtan, Hu'nan, China</contact_address>
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>